This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novo Nordisk A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Harini Sivagurunatha Krishnan: Innovator in Cancer Treatment
Introduction
Harini Sivagurunatha Krishnan is a notable inventor based in Lexington, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic solutions. Her work focuses on targeting specific gene expressions to improve patient outcomes.
Latest Patents
Harini holds a patent for "STAT3 targeting oligonucleotides and uses thereof." This patent involves the modulation of STAT3 gene expression using siRNA compositions. The methods disclosed aim to affect key cell populations that support the growth and metastasis of cancer, ultimately contributing to the beneficial treatment, remission, or removal of underlying tumors in patients. She has 1 patent to her name.
Career Highlights
Harini is currently employed at Novo Nordisk A/S, where she continues to advance her research in the field of biotechnology and pharmaceuticals. Her work at the company emphasizes the importance of innovative solutions in treating complex diseases such as cancer.
Collaborations
Some of her notable coworkers include Henryk T Dudek and Shanthi Ganesh, who collaborate with her on various projects aimed at enhancing cancer treatment methodologies.
Conclusion
Harini Sivagurunatha Krishnan is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovative research in medicine. Her contributions are vital in the ongoing fight against cancer, and her patent reflects her commitment to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile